Development and Validation of a Machine Learning-Based Radiomics Model Using Ultrasound Image Features for Prostate Cancer Risk Stratification.
1/5 보강
[AIM] This study aimed to construct a risk stratification model for prostate cancer (PCa) ultrasound imaging data and machine learning algorithms, with the goal of providing an effective tool for earl
- Sensitivity 88%
- Specificity 90%
APA
Zhao A, Du S, et al. (2026). Development and Validation of a Machine Learning-Based Radiomics Model Using Ultrasound Image Features for Prostate Cancer Risk Stratification.. Annali italiani di chirurgia, 97(1), 63-73. https://doi.org/10.62713/aic.4250
MLA
Zhao A, et al.. "Development and Validation of a Machine Learning-Based Radiomics Model Using Ultrasound Image Features for Prostate Cancer Risk Stratification.." Annali italiani di chirurgia, vol. 97, no. 1, 2026, pp. 63-73.
PMID
41537209 ↗
Abstract 한글 요약
[AIM] This study aimed to construct a risk stratification model for prostate cancer (PCa) ultrasound imaging data and machine learning algorithms, with the goal of providing an effective tool for early diagnosis, personalized treatment, and clinical decision-making.
[METHODS] A total of 211 histopathologically confirmed PCa patients were retrospectively enrolled and categorized into low-risk ( = 65), intermediate-risk ( = 55), and high-risk ( = 91) groups based on prostate-specific antigen levels, Gleason scores, and clinical T stage. From ultrasound images, 135 quantitative radiomic features-including morphological, texture, and edge descriptors-were extracted using the PyRadiomics toolkit. Feature dimensionality was reduced using the Pearson correlation coefficient (PCC), followed by recursive feature elimination (RFE) with 10-fold nested cross-validation to select the most informative features. Three machine learning algorithms-support vector machine (SVM), random forest (RF), and logistic regression (LR)-were trained and evaluated. Model performance was assessed using accuracy, sensitivity, specificity, and area under the curve (AUC).
[RESULTS] The RF model achieved the best performance in both training and test cohorts, with AUCs of 0.87 and 0.86, and accuracies of 90% and 88%, respectively. DeLong's test confirmed that RF significantly outperformed SVM ( = 0.016) and LR ( = 0.004) in AUC comparison. The RF model also demonstrated robust predictive ability across risk subgroups: in the high-risk group, it achieved an AUC of 0.89, accuracy of 89%, sensitivity of 88%, and specificity of 90%; in the intermediate- and low-risk groups, AUCs were 0.86 and 0.81, respectively. Feature importance analysis revealed that wavelet-transformed Gray Level Dependence Matrix (GLDM) texture features, particularly DependenceEntropy and DependenceVariance, were the most predictive, highlighting the value of intratumoral textural heterogeneity in risk classification.
[CONCLUSIONS] The RF-based ultrasound radiomics model enables accurate stratification of PCa risk, with remarkable performance in identifying high-risk patients.
[METHODS] A total of 211 histopathologically confirmed PCa patients were retrospectively enrolled and categorized into low-risk ( = 65), intermediate-risk ( = 55), and high-risk ( = 91) groups based on prostate-specific antigen levels, Gleason scores, and clinical T stage. From ultrasound images, 135 quantitative radiomic features-including morphological, texture, and edge descriptors-were extracted using the PyRadiomics toolkit. Feature dimensionality was reduced using the Pearson correlation coefficient (PCC), followed by recursive feature elimination (RFE) with 10-fold nested cross-validation to select the most informative features. Three machine learning algorithms-support vector machine (SVM), random forest (RF), and logistic regression (LR)-were trained and evaluated. Model performance was assessed using accuracy, sensitivity, specificity, and area under the curve (AUC).
[RESULTS] The RF model achieved the best performance in both training and test cohorts, with AUCs of 0.87 and 0.86, and accuracies of 90% and 88%, respectively. DeLong's test confirmed that RF significantly outperformed SVM ( = 0.016) and LR ( = 0.004) in AUC comparison. The RF model also demonstrated robust predictive ability across risk subgroups: in the high-risk group, it achieved an AUC of 0.89, accuracy of 89%, sensitivity of 88%, and specificity of 90%; in the intermediate- and low-risk groups, AUCs were 0.86 and 0.81, respectively. Feature importance analysis revealed that wavelet-transformed Gray Level Dependence Matrix (GLDM) texture features, particularly DependenceEntropy and DependenceVariance, were the most predictive, highlighting the value of intratumoral textural heterogeneity in risk classification.
[CONCLUSIONS] The RF-based ultrasound radiomics model enables accurate stratification of PCa risk, with remarkable performance in identifying high-risk patients.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Correction: EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Progression.
- The controlled synthesis of PdAg alloy nanospheres and the selective oxidation of ethylene glycol.
- EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Progression.
- Construction of soluble sufentanil microneedles and their analgesic effects in a mouse model of cancer pain.
- ASO Author Reflections: EMC3 in HCC-A Novel Regulator of PI3K/AKT/mTOR Signaling and Tumor Immunity.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.